JRSIS HEALTH CARE CORPORATION Foreign Currency Transaction Gain (Loss), before Tax
JRSIS HEALTH CARE CORPORATION (JRSS) reported Foreign Currency Transaction Gain (Loss), before Tax of $2.20 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-26.
Discontinued › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2024-04-26
- JRSIS HEALTH CARE CORPORATION foreign currency transaction gain (loss), before tax for the quarter ending 2023-12-31 was -$3.51K.
- JRSIS HEALTH CARE CORPORATION foreign currency transaction gain (loss), before tax for the quarter ending 2023-09-30 was $874.00, a 76.64% decline year-over-year.
- JRSIS HEALTH CARE CORPORATION foreign currency transaction gain (loss), before tax for the quarter ending 2023-06-30 was $5.10K, a 19.76% decline year-over-year.
- JRSIS HEALTH CARE CORPORATION foreign currency transaction gain (loss), before tax for the quarter ending 2023-03-31 was -$257.00, a 100.12% decline year-over-year.
- JRSIS HEALTH CARE CORPORATION foreign currency transaction gain (loss), before tax for fiscal 2023 was $2.20K, a 95.86% decline from fiscal 2022.
- JRSIS HEALTH CARE CORPORATION foreign currency transaction gain (loss), before tax for fiscal 2022 was $53.19K, a 94.29% decline from fiscal 2021.
- JRSIS HEALTH CARE CORPORATION foreign currency transaction gain (loss), before tax for fiscal 2021 was $931.38K, a 42.21% decline from fiscal 2020.
- JRSIS HEALTH CARE CORPORATION foreign currency transaction gain (loss), before tax for fiscal 2020 was $1.61M.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month as first filed |
|---|---|---|---|---|---|
| 2023-12-31 | -$3.51K derived: 10-K 12 month − 3 quarters · filed 2024-04-26 | -$2.64K derived: sum of 2 quarters · filed 2024-04-26 | $2.46K derived: sum of 3 quarters · filed 2024-04-26 | $2.20K 10-K · filed 2024-04-26 | |
| 2023-09-30 | $874.00 10-Q · filed 2023-11-15 | $5.97K derived: sum of 2 quarters · filed 2023-11-15 | $5.72K derived: sum of 3 quarters · filed 2023-11-15 | ||
| 2023-06-30 | $5.10K 10-Q · filed 2023-11-15 | $4.84K derived: sum of 2 quarters · filed 2023-11-15 | |||
| 2023-03-31 | -$257.00 10-Q · filed 2023-11-15 | ||||
| 2022-12-31 | $53.19K 10-K · filed 2024-04-26 | $214.41K 10-K · filed 2023-04-17 | |||
| 2022-09-30 | $3.74K 10-Q · filed 2023-11-15 | $10.10K derived: sum of 2 quarters · filed 2023-11-15 | $218.31K derived: sum of 3 quarters · filed 2023-11-15 | ||
| 2022-06-30 | $6.36K 10-Q · filed 2023-11-15 | $214.57K derived: sum of 2 quarters · filed 2023-11-15 | |||
| 2022-03-31 | $208.21K 10-Q · filed 2023-11-15 | ||||
| 2021-12-31 | $931.38K 10-K/A · filed 2023-08-31 | ||||
| 2021-09-30 | $7.36K 10-Q · filed 2022-11-14 | $479.21K derived: sum of 2 quarters · filed 2022-11-14 | $405.46K derived: sum of 3 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $471.86K 10-Q · filed 2022-11-14 | $398.11K derived: sum of 2 quarters · filed 2022-11-14 | |||
| 2021-03-31 | -$73.75K 10-Q · filed 2022-11-14 | ||||
| 2020-12-31 | $1.61M 10-K · filed 2022-04-15 |